Corcept Therapeutics, Inc. (CORT)
32.15
-0.24
(-0.74%)
USD |
NASDAQ |
Mar 13, 16:00
32.17
+0.02
(+0.06%)
Pre-Market: 20:00
Corcept Therapeutics Profit Margin (Quarterly) : 11.83% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | -14.57% |
| Alphatec Holdings, Inc. | -10.20% |
| Harrow, Inc. | 7.44% |
| Ultragenyx Pharmaceutical, Inc. | -62.32% |
| Amneal Pharmaceuticals, Inc. | 6.09% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.97% |
| Return on Assets | 11.83% |
| Return on Invested Capital | 14.82% |
| Gross Profit Margin (Quarterly) | 98.74% |
| Operating Margin (Quarterly) | 2.22% |
| Return on Net Operating Assets | 101.3% |